The Senior Research Specialist will be working in the laboratory of Dr. Feinman investigating the microbiome-immune-myeloma axis. The successful candidate will participate in identifying microbiota-associated immune biomarkers that have prognostic and therapeutic potential in myeloma, ultimately leading to microbiota-centered interventions that overcome resistance to immunotherapy. The research will include both preclinical and translational studies. Experience in mouse models of disease, husbandry and basic molecular/immunologic assays will be useful to the position.
The Center for Discovery and Innovation- CDI was established by Hackensack Meridian Health (HMH) as an academic basic and translational research enterprise to rapidly translate science innovation to the clinic and to improve outcomes for patients with cancer, infectious diseases, autoimmune disease and other acute and chronic diseases. The CDI has grown rapidly since its origins in 2019, and now has 39 labs, 200+ scientists and allied personnel supported by 78 NIH and DoD grants and more than 87 other grants and contracts. Areas of expertise include genomics, epigenetics, drug resistance, stem cell biology, drug discovery, diagnostics and biomarker development, rheumatology and pharmacology.
A day in the life of a Senior Research Specialist, CDI at Hackensack Meridian Health includes:
Education, Knowledge, Skills and Abilities Required:
Education, Knowledge, Skills and Abilities Preferred:
If you feel that the above description speaks directly to your strengths and capabilities, then please apply today!
Software Powered by iCIMS
www.icims.com